Literature DB >> 6271806

High skeletal muscle adenylate cyclase in malignant hyperthermia.

J H Willner, C G Cerri, D S Wood.   

Abstract

Malignant hyperthermia occurs in humans with several congenital myopathies, usually in response to general anesthesia. Commonly, individuals who develop this syndrome lack symptoms of muscle disease, and their muscle lacks specific pathological changes. A biochemical marker for this myopathy has not previously been available; we found activity of adenylate cyclase and content of cyclic AMP to be abnormally high in skeletal muscle. Secondary modification of protein phosphorylation could explain observed abnormalities of phosphorylase activation and sarcoplasmic reticulum function.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6271806      PMCID: PMC370904          DOI: 10.1172/jci110355

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Anaesthetic deaths in a family.

Authors:  M A DENBOROUGH; J F FORSTER; R R LOVELL; P A MAPLESTONE; J D VILLIERS
Journal:  Br J Anaesth       Date:  1962-06       Impact factor: 9.166

2.  Effects of isoflurane and halothane on contractility and the cyclic 3', 5'-adenosine monophosphate system in the rat aorta.

Authors:  D H Sprague; J C Yang; S H Ngai
Journal:  Anesthesiology       Date:  1974-02       Impact factor: 7.892

3.  Adenylate cyclase in skeletal muscle. Kinetic properties and hormonal stimulation.

Authors:  D L Severson; G I Drummond; P V Sulakhe
Journal:  J Biol Chem       Date:  1972-05-10       Impact factor: 5.157

4.  Editorial: Malignant hyperthermia: a pharmacogenetic disease of skeletal and cardiac muscle.

Authors:  B A Britt
Journal:  N Engl J Med       Date:  1974-05-16       Impact factor: 91.245

5.  Central-core disease and malignant hyperpyrexia.

Authors:  M A Denborough; X Dennett; R M Anderson
Journal:  Br Med J       Date:  1973-02-03

6.  Malignant hyperthermia: an investigation of five patients.

Authors:  B A Britt; W Kalow; A Gordon; J G Humphrey; N B Rewcastle
Journal:  Can Anaesth Soc J       Date:  1973-07

7.  Hereditary aspects of malignant hyperthermia.

Authors:  B A Britt; W G Locher; W Kalow
Journal:  Can Anaesth Soc J       Date:  1969-03

8.  Anesthetic-induced malignant hyperpyrexia in children.

Authors:  J O King; M A Denborough
Journal:  J Pediatr       Date:  1973-07       Impact factor: 4.406

9.  Influence of fluothane on calcium accumulation by the heavy microsomal fraction of human skeletal muscle: comparison with a patient with malignant hyperpyrexia.

Authors:  N S Dhalla; P V Sulakhe; N F Clinch; J G Wade; A Naimark
Journal:  Biochem Med       Date:  1972-08

10.  Effects of halothane on the cyclic 3',5'-adenosine monophosphate (cyclic AMP) system in rat uterine muscle.

Authors:  J C Yang; L Triner; Y Vulliemoz; M Verosky; S H Ngai
Journal:  Anesthesiology       Date:  1973-03       Impact factor: 7.892

View more
  2 in total

1.  Porcine malignant hyperthermia susceptibility: increased calcium-sequestering activity of skeletal muscle sarcoplasmic reticulum.

Authors:  P J O'Brien
Journal:  Can J Vet Res       Date:  1986-07       Impact factor: 1.310

2.  Effects of theophylline on anesthetized malignant hyperthermia-susceptible pigs.

Authors:  Marko Fiege; Ralf Weisshorn; Kerstin Kolodzie; Frank Wappler; Mark U Gerbershagen
Journal:  J Biomed Biotechnol       Date:  2011-10-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.